STOCK TITAN

CONVATEC GRP PLC UNSP/ADR - CNVVY STOCK NEWS

Welcome to our dedicated page for CONVATEC GRP PLC UNSP/ADR news (Ticker: CNVVY), a resource for investors and traders seeking the latest updates and insights on CONVATEC GRP PLC UNSP/ADR stock.

Convatec is a global medical products and technologies company that specializes in wound therapeutics, ostomy care, continence, and critical care, as well as infusion devices. The company's products offer various clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes, and reduced total cost of care. Some of Convatec's well-known brands include Aquacel® advanced wound dressings, which create an optimal healing environment by forming a gel when in contact with wound fluid. With over 9,000 employees and 11 manufacturing sites in 8 countries, Convatec operates in more than 100 countries. The company is owned by Nordic Capital and Avista Capital Partners.

Rhea-AI Summary
Convatec launches Esteem Body™ with Leak Defense™, a soft convexity ostomy system addressing global obesity challenges. The product offers a comprehensive range of pouching solutions with innovative features like gold-standard adhesives, '8-shape' pouch design, and Finite Element Analysis simulations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Convatec has announced that the FDA has cleared its InnovaBurn® placental extracellular matrix medical device for the management of complex surgical wounds and burns, particularly partial-thickness second-degree burns. This device is part of Convatec's InnovaMatrix® platform, representing a significant advancement in ECM technology. The InnovaBurn® device is ready for commercial use, featuring unique sizing and ease of application, which can enhance patient access to advanced treatment options. Approximately 500,000 individuals seek medical treatment for burns each year; thus, this innovative solution aligns with unmet clinical needs in wound management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Convatec has received FDA clearance for its InnovaMatrix® PD particulate placental extracellular matrix medical device, marking it as the first of its kind for wound management. This innovative device is designed specifically for managing complex surgical wounds, chronic stalled wounds, and burns. Joining Convatec's existing InnovaMatrix® AC product, it provides physicians with a reliable tool that replaces older human-derived products no longer available. The device requires no preparation or special storage, leveraging Convatec's TriCleanse™ technology for enhanced safety and effectiveness in healing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of CONVATEC GRP PLC UNSP/ADR (CNVVY)?

The current stock price of CONVATEC GRP PLC UNSP/ADR (CNVVY) is $11.96 as of October 15, 2024.

What is the market cap of CONVATEC GRP PLC UNSP/ADR (CNVVY)?

The market cap of CONVATEC GRP PLC UNSP/ADR (CNVVY) is approximately 6.3B.

What is Convatec known for?

Convatec is known for its expertise in wound therapeutics, ostomy care, continence, critical care, and infusion devices.

How many manufacturing sites does Convatec have?

Convatec operates 11 manufacturing sites in 8 different countries.

Who owns Convatec?

Convatec is owned by Nordic Capital and Avista Capital Partners.

What are some of Convatec's well-known brands?

Some of Convatec's popular brands include Aquacel® advanced wound dressings.

Where does Convatec do business?

Convatec operates in more than 100 countries globally.

What are the benefits of Convatec's products?

Convatec's products offer benefits like infection prevention, skin protection, improved patient outcomes, and reduced care costs.

What is the mission of Convatec?

Convatec's mission is to improve the lives of patients through its medical products and technologies.

What makes Convatec's wound dressings unique?

Convatec's Aquacel® wound dressings create an optimal healing environment by forming a gel when exposed to wound fluid.

How many employees does Convatec have?

Convatec has over 9,000 employees worldwide.

What sectors does Convatec specialize in?

Convatec specializes in wound therapeutics, ostomy care, continence, and critical care, as well as infusion devices.
CONVATEC GRP PLC UNSP/ADR

OTC:CNVVY

CNVVY Rankings

CNVVY Stock Data

6.32B
512.45M
Medical Instruments & Supplies
Healthcare
Link
United States of America
London